查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1549738

黏附包装：市场占有率分析、行业趋势和成长预测（2024-2029）

Adherence Packaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

黏附包装市场规模预计到2024年为10.4亿美元，预计到2029年将达到14.4亿美元，在预测期内（2024-2029年）复合年增长率为6.72%。

黏附性包装市场

主要亮点

  • 依从性包装主要用于医疗保健领域，它取代了传统的药盒，以简化药物管理。这种包装适合患者的日常生活，使其更容易按照医疗保健提供者的指示及时、准确地服用处方笺。
  • 在慢性阻塞性肺病（COPD）患者中，药物治疗和疾病管理依从性差是导致紧急住院的已知因素。因此，对黏附包装的需求正在上升，预计在不久的将来会有显着增长。
  • 此外，人们对尽量减少药物浪费的兴趣日益浓厚，这也正在加强依从性包装产业的发​​展。废弃物不仅给医疗保健财政带来压力，也带来环境风险。然而，该行业面临挑战，特别是高昂的实施、安装和维护成本，这可能会阻碍全球扩张。
  • 包装技术的最新进展正在使用近距离场通讯(NFC) 和无线射频识别 (RFID) 整合数位撷取功能。这些创新旨在加强检验过程。具有被动、主动和互动元素的单位剂量泡壳处于应对鸦片类药物危机和提高药物安全性的最前线。被动元素包括基于图形和文字的警报，而主动功能则利用电子设备进行及时提醒和警报。互动功能让患者参与该套餐，并协助药物追踪和成瘾管理。
  • 一些公司正在积极寻求新产品发布和策略合作伙伴关係等策略，以在不断变化的环境中保持竞争力。特别是，Acute Technology，一家技术主导的药物依从性公司，正在推广 Hydra Communications Gateway。该技术可以让智慧型手机使用者以电子方式监控他们的药物剂量，解决管理每週托盘中分配的药物的问题。
  • 吉利德（Gilead）和礼来（Eli Lilly）等製药巨头处于对抗 COVID-19 的前线。他们的股价飙升，反映出人们重新关注创新，特别是在感染疾病领域。由于迫切寻找 COVID-19 治疗方法，活动激增，可能会对黏附包装市场产生重大影响。总之，先进包装和主要製药公司对 COVID-19 治疗的投资增加预计将推动黏附包装市场的显着成长。

遵守包装市场趋势

大批量包装预计将显着成长

  • 药物依从性的日益重要和药物同步的好处正在刺激多药物包装解决方案的出现。多剂量泡壳卡有几个好处，包括简化给药时间表以减少混乱、鼓励自我治疗以及减少每月去药房的次数。大量研究支持多剂量泡壳包装可改善药物依从性和健康结果，尤其是与药物治疗管理 (MTM) 结合时。
  • 印度品牌股权基金会（IBEF）的报告显示，2024财年（截至2024年2月）印度药品出口额达250亿美元，高于2023财年的254亿美元。在全球供应链中断、停工和製造业低迷的背景下，这种弹性是显着的。值得注意的是，美国、比利时、南非、英国和巴西已成为印度 2023 财年的主要出口目的地。印度在全球製药业中发挥着举足轻重的作用，其表现显示出其在危机面前坚定不移的信誉，尤其是在疫情不断升级的情况下。
  • 据 IBEF 称，印度在美国境外运营的符合 USFDA 要求的公司数量最多。值得注意的是，全球排名前 20 名的学名药公司中有 8 家是印度公司，超过一半（55%）的出口针对高度监管的市场。作为主要疫苗出口国，印度满足世界卫生组织（WHO）65-70%的疫苗需求。
  • Omnicel 的研究结果强调了多药包装对病人依从性的影响。最初，该组患者的依从率为 80%，但在试验结束时跃升至 90%。另一方面，仅依赖锭剂的患者的服药顺从率为 56%。 Omnicell 的解决方案 SureMed+ 是一种 7 天、4 剂量、冷封、双折卡，在 Omnicell 提供多药泡壳卡后，霍利奥克健康中心采用了该解决方案。
  • 电子商务公司越来越关注便利性、合规性和增强老年人的医疗保健套餐。亚马逊去年收购了 Pillpack，证实了线上药物输送的需求不断增长，并表明人们对多功能医疗包的兴趣日益浓厚。随着 COVID-19 的爆发，多剂量包装至关重要，因为它旨在简化处方笺处理、最大限度地减少「接触点」并减少自我用药错误。

北美市场占据主导地位

  • 北美地区是一个发展中地区，拥有丰富的经济、人口老化和先进的医疗保健服务系统。然而，各国的人口规模、医疗保健支出、国内生产总值(GDP) 水准和医疗保险体系差异很大。美国拥有先进的初级保健社区、广泛的医疗和生命科学研究活动、高健康支出强度以及庞大的製药、医疗用品和医疗设备产业，是世界上最大的黏附包装产品市场之一。
  • 此外，美国惩教机构的用药依从性正在改善。大多数惩教设施中的人们依靠外部药房来处方笺。该机构也可能有一名药剂师在场。然而，这类人员往往有限，依赖集中地点提供药品，并依靠现场护理人员管理人员和其他人员进行配药。因此，为了确保病人用药依从性，越来越需要一种减轻工作人员负担、管理良好的配药管理系统。
  • 据 Parata Systems 称，药物依从性差每年给美国造成 3,000 亿美元的损失。小袋包装降低了医疗成本并改善了患者的治疗效果。随着市场上带状包装的增加，患者意识预计会对药房带来压力，而没有适当的包装会被抛在后面。该公司针对药局推出了 Parata PASSTM 36。 Parata Systems 是一家药局自动化系统供应商，产品包括管瓶灌装、依从性包装工作流程和病患体验解决方案，推出了一款名为 PASSTM 36 的袋包装机。
  • 该地区的公司致力于帮助人们保持用药依从性并改善治疗结果。为了实现这一目标，我们越来越多地与创新市场公司合作，特别是那些与药局有密切联繫的公司。透过这样做，这些公司的目标是将其服务范围扩大到他们所服务的患者。透过利用其初级包装专业知识以及与製药领导者的关係，这些公司准备开发增强依从性的解决方案并扩大其影响。
  • 坚持用药对于改善治疗结果至关重要，并且可以显着减少昂贵的住院费用。在这种情况下，数位化治疗支持备受关注。这种支援超越了传统的穿戴式感测器和应用程序，扩展到连网型包装、输送系统和先进的药物依从性监测。因此，合作伙伴关係和协作不断涌现，为药房提供云端基础的软体和设备。这些工具使药局能够快速实施依从性解决方案，透过最少的工作流程调整来增强患者的健康之旅，并打开新收益来源的大门。

黏合包装产业概述

黏附包装市场是半静态的，由一些重要的参与者组成。 Cardinal Health Inc.、WestRock Company、Omnicell Inc.、Parata Systems LLC 和 Keystone Folding Box Co. 等公司占有很大份额。市场也见证了多种产品的发布和合作伙伴关係。

2024年4月，製药、生物技术和化妆品行业的全球合作伙伴Gerresheimer最近与美国数位健康公司RxCap合作并收购了其少数股权。透过此次合作，Geresheimer 的子公司 Centor 拥有在美国药房分销 RxCap 依从性解决方案的独家权利。这些解决方案包括连网型和云端基础的软体，可增强 Centor 的现有产品。此举凸显了 Gerresheimer 向客户提供整合包装和数位监控解决方案的承诺。

2024 年 4 月，RICHARDS Packaging Inc. 旗下的加拿大医疗供应商 Healthmark Services Ltd. 与 JFCRx 合作。透过此次合作，Healthmark Services Ltd 将成为 JFCRx 贴标袋包装、测试和半自动管瓶灌装製药自动化设备的唯一供应商。 JFCRx 以「分析主导的自动化」而闻名，为药房提供即时资料洞察，以提高业务效率和盈利。该公司的旗舰产品 TruPak 整合了先进的硬体和软体，透过提供 RFID 智慧罐、可自订的袋子尺寸和即时补充等功能来节省劳动力并提高安全性。

其他好处：

  • Excel 格式的市场预测 (ME) 表
  • 3 个月的分析师支持

目录

第一章简介

  • 研究假设和市场定义
  • 调查范围

第二章调查方法

第三章执行摘要

第四章市场洞察

  • 市场概况
  • 产业供应链分析
  • 产业吸引力－波特五力分析
    • 供应商的议价能力
    • 消费者议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争公司之间敌对关係的强度
  • 评估 COVID-19 对产业的影响

第五章市场动态

  • 市场驱动因素
    • 减少药物浪费的需求日益增加
    • 服药不依从率高
  • 市场挑战
    • 自动化系统的安装和维护成本高昂
    • 缺乏对药物依从性包装的认识

第六章 政府法规

第七章 市场区隔

  • 材料
    • 塑胶（PE、PET、PVC、PP）
    • 纸和纸板
    • 铝
  • 类型
    • 单位剂量包装
    • 多药包装
  • 包装类型
    • 泡壳
    • 小袋
    • 其他包装类型
  • 最终用户产业
    • 药局
    • 医院
    • 其他最终用户产业
  • 地区
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东/非洲

第八章 竞争格局

  • 公司简介
    • Westrock Company
    • Keystone Folding Box Co.
    • Cardinal Health Inc.
    • Omnicell Inc.
    • Jones Healthcare Group
    • Drug Package LLC
    • Parata Systems LLC
    • Manrex Limited
    • Medicine-On-Time LLC
    • Rx Systems Inc.

第九章投资分析

第10章市场的未来

简介目录
Product Code: 67618

The Adherence Packaging Market size is estimated at USD 1.04 billion in 2024, and is expected to reach USD 1.44 billion by 2029, growing at a CAGR of 6.72% during the forecast period (2024-2029).

Adherence Packaging - Market

Key Highlights

  • Adherence packaging, predominantly utilized in healthcare, serves to streamline medication management, replacing traditional pill organizers. This packaging aligns with patients' daily routines, facilitating timely and accurate prescription intake as directed by healthcare providers.
  • Inadequate adherence to pharmacological therapy and illness management is a known factor leading to emergency hospitalizations among those with chronic obstructive pulmonary disease (COPD). Consequently, the demand for adherence packaging is on the rise, with projections indicating substantial growth in the near future.
  • Furthermore, a heightened focus on minimizing drug waste is bolstering the adherence packaging sector. Waste not only strains healthcare finances but also poses environmental risks. Yet, the industry faces challenges, notably in the form of high implementation, installation, and maintenance costs, which could potentially impede its global expansion.
  • Recent advancements in packaging technology are integrating digital capture features utilizing near-field communication (NFC) or radio frequency identification (RFID). These innovations aim to enhance verification processes. Unit-dose blisters, equipped with passive, active, and interactive elements, are at the forefront of combating the opioid crisis and bolstering pharmaceutical safety. Passive components include graphic or text-based alerts, while active features leverage electronics for timely reminders or alarms. Interactive functionalities empower patients to engage with the packaging, aiding in dose recording and addiction management.
  • Several companies are actively pursuing strategies, like new product launches and strategic partnerships, to stay competitive in this evolving landscape. Notably, Acute Technology, a company in tech-driven medication adherence, is championing the Hydra Communications Gateway. This technology could potentially allow smartphone users to monitor their dosages electronically, addressing concerns around the control of medications dispensed via weekly trays.
  • Pharmaceutical giants like Gilead and Eli Lilly are at the forefront of the battle against COVID-19. Their stocks are surging, reflecting a renewed focus on innovation, especially in infectious diseases. This heightened activity, driven by the urgent quest for COVID-19 treatments, is poised to have a substantial impact on the adherence packaging market. In conclusion, the advancements and increased investments in COVID-19 therapies by leading pharmaceutical companies are expected to drive significant growth in the adherence packaging market.

Adherence Packaging Market Trends

Multi-dose Packaging is Expected to Witness Significant Growth

  • The rising significance of medication adherence and the advantages of synchronizing medications have spurred the emergence of multi-dose packaging solutions. Multi-dose blister cards offer several benefits, such as streamlining dosage schedules to reduce confusion, facilitating self-medication, and reducing monthly pharmacy visits. Numerous studies underscore the enhanced adherence and health outcomes associated with multi-med blister packs, especially when coupled with medication therapy management (MTM).
  • As reported by the India Brand Equity Foundation (IBEF), India's drug and pharmaceutical exports in FY 2024 (until February 2024) reached USD 25.0 billion, from USD 25.4 billion recorded in FY 2023. This resilience is notable, given the backdrop of global supply chain disruptions, lockdowns, and subdued manufacturing. Notably, the United States, Belgium, South Africa, the United Kingdom, and Brazil emerged as India's primary export destinations in FY 2023. India's performance underscored its pivotal role in the global pharma landscape, showcasing unwavering reliability even in the face of crises, notably exemplified during the COVID-19 pandemic.
  • According to IBEF, India boasts the highest number of USFDA-compliant companies operating outside the United States. Notably, 8 out of the top 20 global generic companies hail from India, and more than half (55%) of the country's exports target highly regulated markets. Given its status as a major vaccine exporter, India fulfills a substantial 65-70% of the World Health Organization's (WHO) vaccine demand.
  • Findings from an Omnicell survey underscore the impact of multimed packaging on patient adherence. Initially, patients in this group achieved an 80% adherence rate, which surged to an impressive 90% by the trial's end. In contrast, patients relying solely on pill bottles managed a modest 56% adherence rate. Omnicell's solution, the SureMed+, a seven-day, four-time pass, cold-seal, bi-fold card, was adopted by Holyoke Health Center following Omnicell's provision of multimed blister cards.
  • E-commerce players are increasingly focusing on enhancing convenience, compliance, and tailored healthcare packaging for the elderly. Amazon's acquisition of PillPack last year underscores the rising demand for online medication delivery, hinting at a growing interest in multi-med packs. With the onset of COVID-19, multi-dose packaging is crucial, aiming to streamline prescription processing, minimize 'touchpoints,' and mitigate self-medication errors.

North America Dominates the Market

  • The North American region is developed with prosperous economies, aging population segments, and advanced medical delivery systems. Still, the countries vary measurably in population size, healthcare spending intensities, aggregate gross domestic product (GDP) levels, and the structure of health insurance plans. With an advanced primary medical community, extensive medical and life science research activities, high healthcare spending intensity, and large pharmaceutical and medical supply and device industries, the United States accounts for one of the world's largest geographical markets for adherence packaging products.
  • Furthermore, the United States is witnessing improved medication adherence in the correctional setting. The incarcerated population in most correctional facilities relies on an outside pharmacy to fill their prescriptions. An onsite pharmacist may be provided in some situations. However, such staff is often restricted, relying on a centralized location to supply drugs and an onsite nurse manager or similar to dispense. This strengthens the case for dispensing administration systems that are low-effort for personnel while yet being well-managed to ensure patient adherence.
  • As per Parata Systems, non-adherence to medication, on average, costs USD 300 billion/year in the United States. Pouch packaging has reduced the cost of care and improved patient outcomes. With the growing presence of strip packaging in the market, patient awareness is expected to pressure pharmacies without proper packaging to be left behind. The company launched Parata PASSTM 36, targeting pharmacies. Parata Systems, being a provider of pharmacy automation systems, including vial-filling, adherence packaging, and workflow and patient experience solutions, launched a pouch packager named PASSTM 36.
  • Businesses in the region are focused on a mission: helping people stay adherent to their medications and improving their care outcomes. To achieve this, they are increasingly forging partnerships with innovative market players, particularly those with strong ties to pharmacies. By doing so, these businesses aim to expand the reach of the patients they serve. Leveraging their expertise in primary packaging and their relationships with pharmacy leaders, these companies are poised to develop enhanced adherence solutions, thereby magnifying their impact.
  • Adherence to medication is pivotal to successful therapy outcomes and can significantly reduce the need for costly hospitalizations. In this landscape, digital therapy support is gaining prominence. This support extends beyond traditional body-worn sensors and apps, encompassing connected primary packaging, delivery systems, and advanced medication adherence monitoring. Consequently, collaborations and alliances are emerging, offering cloud-based software and devices to pharmacies. These tools empower pharmacies to swiftly introduce adherence solutions, bolstering patients' health journeys with minimal workflow adjustments and paving the way for new revenue streams.

Adherence Packaging Industry Overview

The adherence packaging market is semi-consolidated and consists of a few significant players. Companies like Cardinal Health Inc., WestRock Company, Omnicell Inc., Parata Systems LLC, and Keystone Folding Box Co. hold substantial market shares. The market is also witnessing multiple product launches and partnerships.

In April 2024, Gerresheimer, a global partner for the pharma, biotech, and cosmetics industries, recently partnered with US digital health company RxCap, acquiring a minority stake. In this collaboration, Gerresheimer's subsidiary, Centor, gains exclusive US pharmacy distribution rights for RxCap's adherence solutions. These solutions include connected prescription vial closures and cloud-based software, enhancing Centor's existing offerings. This move underscores Gerresheimer's commitment to providing customers with integrated packaging and digital monitoring solutions.

In April 2024, Canadian medical supplier Healthmark Services Ltd, a division of RICHARDS Packaging Inc., teamed up with JFCRx. This partnership designates Healthmark Services Ltd as the sole provider of JFCRx's adherence pouch packaging, inspection, and semi-automated vial filling pharmacy automation equipment. JFCRx, known for its "analytics-driven automation," empowers pharmacies with real-time data insights, enhancing operational efficiency and profitability. Their flagship product, TruPak, integrates advanced hardware and software, offering features like RFID smart canisters, customizable pouch sizes, and on-the-fly replenishment, ensuring both labor savings and enhanced safety.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS

  • 4.1 Market Overview
  • 4.2 Industry Supply Chain Analysis
  • 4.3 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.3.1 Bargaining Power of Suppliers
    • 4.3.2 Bargaining Power of Consumers
    • 4.3.3 Threat of New Entrants
    • 4.3.4 Threat of Substitute Products
    • 4.3.5 Intensity of Competitive Rivalry
  • 4.4 Assessment of the Impact of COVID-19 on the Industry

5 MARKET DYNAMICS

  • 5.1 Market Drivers
    • 5.1.1 Rise in Need to Minimize Medication Wastage
    • 5.1.2 High Rate of Medication Non-adherence
  • 5.2 Market Challenges
    • 5.2.1 High Installation and Maintenance Costs of Automated Systems
    • 5.2.2 Lack of Awareness Regarding Medication Adherence Packaging

6 GOVERNMENT REGULATIONS

7 MARKET SEGMENTATION

  • 7.1 Material
    • 7.1.1 Plastic (PE, PET, PVC, and PP)
    • 7.1.2 Paper and Paperboard
    • 7.1.3 Aluminum
  • 7.2 Type
    • 7.2.1 Unit-dose Packaging
    • 7.2.2 Multi-dose Packaging
  • 7.3 Packaging Type
    • 7.3.1 Blisters
    • 7.3.2 Pouches
    • 7.3.3 Other Packaging Types
  • 7.4 End-user Industry
    • 7.4.1 Pharmacies
    • 7.4.2 Hospitals
    • 7.4.3 Other End-user Industries
  • 7.5 Geography
    • 7.5.1 North America
    • 7.5.2 Europe
    • 7.5.3 Asia-Pacific
    • 7.5.4 Latin America
    • 7.5.5 Middle East and Africa

8 COMPETITIVE LANDSCAPE

  • 8.1 Company Profiles
    • 8.1.1 Westrock Company
    • 8.1.2 Keystone Folding Box Co.
    • 8.1.3 Cardinal Health Inc.
    • 8.1.4 Omnicell Inc.
    • 8.1.5 Jones Healthcare Group
    • 8.1.6 Drug Package LLC
    • 8.1.7 Parata Systems LLC
    • 8.1.8 Manrex Limited
    • 8.1.9 Medicine-On-Time LLC
    • 8.1.10 Rx Systems Inc.

9 INVESTMENT ANALYSIS

10 FUTURE OF THE MARKET